HomeHealthcare & Life SciencesMedical Devices Radiopharmaceutical Synthesizer Market

North America Radiopharmaceutical Synthesizer Market Size & Outlook, 2025-2033


North America Radiopharmaceutical Synthesizer Market Insights

  • As highlighted in Reed Intelligence analysis, the North America Radiopharmaceutical Synthesizer Market, valued at USD 966.54 Million in 2024, is estimated to achieve USD 1415.6 Million by 2033.
  • The market is estimated to grow at a CAGR of 4.32% spanning 2026 to 2033.
  • By market size, PET led the Modality category in 2024.
  • The Modality segment led by PET is estimated to post the fastest growth, sustaining its position as the most lucrative during the forecast timeframe.

Other Key Findings


  • North America held 30.88% share of the global Radiopharmaceutical Synthesizer Market size in 2024.
  • United States is expected to remain the largest contributor to the global market size by 2033.
  • By 2033, Canada is anticipated to record the highest growth in North America, with the market size expected to reach USD 373.03 Million.

Report Summary

Report Scope Details
Base Year for Study 2024
Study Period 2021-2033
Historical Period 2021-2023
Forecast Period 2025-2033
Market Size In 2024 USD 966.54 Million
Market Size In 2033 USD 1415.6 Million
Largest segment PET
Units Revenue in USD Million
CAGR 4.32% (2025-2033)
Segmnetation Covered
North America
  1. United States
  2. Canada
Modality
  1. PET
  2. SPECT
  3. Others
Application
  1. Oncology
  2. Cardiology
  3. Neurology
  4. Others
Radioisotope
  1. Fluorine-18
  2. Carbon-11
  3. Gallium-68
  4. Others
Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends

Related Reports